These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23465406)

  • 1. Dopamine-resistant hypotension and severe retinopathy of prematurity.
    Catenacci M; Miyagi S; Wickremasinghe AC; Lucas SS; de Alba Campomanes AG; Good WV; Clyman RI
    J Pediatr; 2013 Aug; 163(2):400-5. PubMed ID: 23465406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity.
    Yang MB; Rao S; Copenhagen DR; Lang RA
    Ophthalmology; 2013 Dec; 120(12):2706-2713. PubMed ID: 24139125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of prematurity: risk stratification by gestational age.
    Wu T; Rao R; Gu H; Lee A; Reynolds M
    J Perinatol; 2023 Jun; 43(6):694-701. PubMed ID: 36653668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Risk Factors Shared by Bronchopulmonary Dysplasia, Severe Retinopathy, and Cystic Periventricular Leukomalacia in Very Preterm Infants for Targeted Intervention.
    Wang LW; Lin YC; Wang ST; Huang CC;
    Neonatology; 2018; 114(1):17-24. PubMed ID: 29621770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones.
    Clyman RI; Wickremasinghe A; Merritt TA; Solomon T; McNamara P; Jain A; Singh J; Chu A; Noori S; Sekar K; Lavoie PM; Attridge JT; Swanson JR; Gillam-Krakauer M; Reese J; DeMauro S; Poindexter B; Aucott S; Satpute M; Fernandez E; Auchus RJ;
    J Pediatr; 2014 Jun; 164(6):1449-55.e1. PubMed ID: 24636853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.
    Saldeño YP; Favareto V; Mirpuri J
    J Perinatol; 2012 Dec; 32(12):953-8. PubMed ID: 22460543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.
    Hellström A; Engström E; Hård AL; Albertsson-Wikland K; Carlsson B; Niklasson A; Löfqvist C; Svensson E; Holm S; Ewald U; Holmström G; Smith LE
    Pediatrics; 2003 Nov; 112(5):1016-20. PubMed ID: 14595040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia as a risk factor for the development of retinopathy of prematurity.
    Mohamed S; Murray JC; Dagle JM; Colaizy T
    BMC Pediatr; 2013 May; 13():78. PubMed ID: 23679669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine use is an indicator for the development of threshold retinopathy of prematurity.
    Mizoguchi MB; Chu TG; Murphy FM; Willits N; Morse LS
    Br J Ophthalmol; 1999 Apr; 83(4):425-8. PubMed ID: 10434864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between severe retinopathy of prematurity and postnatal weight gain in very low-birthweight infants at Chiang Mai University Hospital, Thailand.
    Wongnophirun A; Khuwuthyakorn V; Tantiprabha W; Wiwatwongwana A
    Paediatr Int Child Health; 2020 May; 40(2):85-91. PubMed ID: 31272307
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk Factors for Retinopathy of Prematurity in the Netherlands: A Comparison of Two Cohorts.
    Trzcionkowska K; Groenendaal F; Andriessen P; Dijk PH; van den Dungen FAM; van Hillegersberg JL; Koole S; Kornelisse RF; van Westering-Kroon E; von Lindern JS; Meijssen CB; Schuerman FABA; Steiner K; van Tuyl MWG; Witlox RSGM; Schalij-Delfos NE; Termote JUM
    Neonatology; 2021; 118(4):462-469. PubMed ID: 34293743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National trends in the incidence and management of retinopathy of prematurity in the United States, 2009 -2018.
    Cudjoe GA; Ameley A; Ohemeng-Dapaah J; Bhatt P; Donda K; Dapaah-Siakwan F
    J Neonatal Perinatal Med; 2022; 15(3):553-557. PubMed ID: 35491807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation.
    Noori S; McNamara P; Jain A; Lavoie PM; Wickremasinghe A; Merritt TA; Solomon T; Sekar K; Attridge JT; Swanson JR; Gillam-Krakauer M; Reese J; Poindexter BB; Brook M; Auchus RJ; Clyman RI;
    J Perinatol; 2015 Feb; 35(2):123-7. PubMed ID: 25118721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates.
    Kumar P; Sankar MJ; Deorari A; Azad R; Chandra P; Agarwal R; Paul V
    Indian J Pediatr; 2011 Jul; 78(7):812-6. PubMed ID: 21340729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates.
    Brown DR; Milley JR; Ripepi UJ; Biglan AW
    Am J Dis Child; 1987 Feb; 141(2):154-60. PubMed ID: 3101483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis.
    Gerull R; Brauer V; Bassler D; Laubscher B; Pfister RE; Nelle M; Müller B; Gerth-Kahlert C; Adams M;
    Arch Dis Child Fetal Neonatal Ed; 2018 Jul; 103(4):F337-F342. PubMed ID: 28916563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study.
    Kang SL; Samsudin S; Kuruvilla M; Dhelaria A; Kent S; Kelsall WA
    Cardiol Young; 2013 Oct; 23(5):711-6. PubMed ID: 23164413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is patent ductus arteriosus a risk factor for retinopathy of prematurity?].
    González Viejo I; Ferrer Novella C; Pueyo Royo V; García Martín E; Rite Gracia S; Caballero Pérez V; Romera Santa Bárbara B; Royo Pérez D
    An Pediatr (Barc); 2011 Jan; 74(1):25-30. PubMed ID: 20888311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants.
    Bourchier D; Weston PJ
    Arch Dis Child Fetal Neonatal Ed; 1997 May; 76(3):F174-8. PubMed ID: 9175947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
    Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.